Calcitonin Gene-Related Peptide In Vivo Positive Inotropy Is Attributable to Regional Sympatho-Stimulation and Is Blunted in Congestive Heart Failure

Calcitonin gene-related peptide (CGRP) is a nonadrenergic/noncholinergic (NANC) peptide with vasodilatative/inotropic action that may benefit the failing heart. However, precise mechanisms for its in vivo inotropic action remain unclear. To assess this, dogs with normal or failing (sustained tachypacing) hearts were instrumented for pressure–dimension analysis. In control hearts, CGRP (20 pmol/kg per minute) enhanced cardiac contractility (eg, +33±4.2% in end-systolic elastance) and lowered afterload (−14.2±2% in systemic resistance, both P<0.001). The inotropic response was markedly blunted by heart failure (+6.5±2%; P<0.001 versus control), whereas arterial dilation remained unaltered (−19.3±5%). CGRP-positive inotropy was not attributable to reflex activation because similar changes were observed in the presence of a ganglionic blocker. However, it was fully prevented by the &bgr;-receptor antagonist (timolol), identifying a dominant role of sympatho-stimulatory signaling. In control hearts, myocardial interstitial norepinephrine assessed by microdialysis almost doubled in response to CGRP infusion, whereas systemic plasma levels were unchanged. In addition, CGRP receptors were not observed in ventricular myocardium but were prominent in coronary arteries and the stellate ganglia. Ventricular myocytes isolated from normal and failing hearts displayed no inotropic response to CGRP, further supporting indirect sympatho-stimulation as the primary in vivo mechanism. In contrast, the peripheral vasodilatative capacity of CGRP was similar in femoral vascular rings from normal and failing hearts in dogs. Thus, CGRP-mediated positive inotropy is load-independent but indirect and attributable to myocardial sympathetic activation rather than receptor-coupled stimulation in canine hearts. This mechanism is suppressed in heart failure, so that afterload reduction accounts for CGRP-enhanced function in this setting.

[1]  C. Gennari,et al.  Cardiovascular action of calcitonin gene-related peptide in humans , 1985, Calcified Tissue International.

[2]  S. Brain,et al.  Vascular actions of calcitonin gene-related peptide and adrenomedullin. , 2004, Physiological reviews.

[3]  Y. Kurachi,et al.  Effects of calcitonin gene-related peptide on membrane currents in mammalian cardiac myocytes , 1991, Pflügers Archiv.

[4]  D. Kass,et al.  Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm. , 2003, American journal of physiology. Heart and circulatory physiology.

[5]  R. Hargreaves,et al.  Effects of Inhibition of &agr;-CGRP Receptors on Cardiac and Peripheral Vascular Dynamics in Conscious Dogs with Chronic Heart Failure , 2003 .

[6]  D. Kass,et al.  Positive inotropic and lusitropic effects of HNO/NO− in failing hearts: Independence from β-adrenergic signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Hargreaves,et al.  Effects of inhibition of alpha-CGRP receptors on cardiac and peripheral vascular dynamics in conscious dogs with chronic heart failure. , 2003, Journal of cardiovascular pharmacology.

[8]  G. Mcgregor,et al.  Calcitonin receptor-like receptor: identification and distribution in human peripheral tissues , 2002, Cell and Tissue Research.

[9]  R. Ventura-clapier,et al.  Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure. , 2002, Biochemical and biophysical research communications.

[10]  H. Nishimatsu,et al.  Elevated Sympathetic Nervous Activity in Mice Deficient in &agr;CGRP , 2001, Circulation research.

[11]  D. Kass,et al.  Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Dell’Italia,et al.  Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo. , 2001, American journal of physiology. Heart and circulatory physiology.

[13]  V. Antipova,et al.  Expression of vasoactive intestinal polypeptide and calcitonin gene-related peptide in human stellate ganglia after acute myocardial infarction. , 2001, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[14]  O. Schmitt,et al.  Upregulation of vasoactive intestinal polypeptide (VIP) and calcitonin gene-related peptide (CGRP) expression in stellate ganglia of children with congenital cardiovascular lesions. , 2001, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[15]  T. Hintze,et al.  cAMP Signal Transduction Cascade, a Novel Pathway for the Regulation of Endothelial Nitric Oxide Production in Coronary Blood Vessels , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  D. Hoover,et al.  Regional localization and abundance of calcitonin gene-related peptide receptors in guinea pig heart. , 2001, Journal of molecular and cellular cardiology.

[17]  Alpar,et al.  Neuropeptide variability in man , 2000, European journal of clinical investigation.

[18]  L. Edvinsson,et al.  Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae. , 2000, European journal of pharmacology.

[19]  D. Kass,et al.  Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033. , 2000, Circulation.

[20]  K. Westlund,et al.  Increased Blood Pressure in α-Calcitonin Gene–Related Peptide/Calcitonin Gene Knockout Mice , 2000 .

[21]  K. Westlund,et al.  Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. , 2000, Hypertension.

[22]  R. Levi,et al.  Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norepinephrine release? , 1999, The Journal of pharmacology and experimental therapeutics.

[23]  J. Izzo,et al.  Ca2+-induced Ca2+ release involved in positive inotropic effect mediated by CGRP in ventricular myocytes. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[24]  M. Sugimachi,et al.  Interstitial norepinephrine level by cardiac microdialysis correlates with ventricular contractility. , 1997, The American journal of physiology.

[25]  R. Cardinal,et al.  Reduced capacity of cardiac efferent sympathetic neurons to release noradrenaline and modify cardiac function in tachycardia-induced canine heart failure. , 1996, Canadian journal of physiology and pharmacology.

[26]  Y. Ishikawa,et al.  β‐ADRENOCEPTOR DESENSITIZATION DURING THE DEVELOPMENT OF CANINE PACING‐INDUCED HEART FAILURE , 1996, Clinical and experimental pharmacology & physiology.

[27]  B. McDermott,et al.  Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. , 1996, Pharmacological reviews.

[28]  M. Garbarg,et al.  Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. , 1996, Circulation research.

[29]  L. Edvinsson,et al.  Different levels of sensory neuropeptides (calcitonin gene-related peptide and substance P) during and after exercise in man. , 1996, Clinical physiology.

[30]  P. Saxena,et al.  Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. , 1994, European journal of pharmacology.

[31]  A. Bonev,et al.  Calcitonin gene‐related peptide activated ATP‐sensitive K+ currents in rabbit arterial smooth muscle via protein kinase A. , 1994, The Journal of physiology.

[32]  A. Rubino.  Non-adrenergic non-cholinergic (NANC) neural control of the atrial myocardium. , 1993, General pharmacology.

[33]  R. Bache,et al.  Effect of Calcitonin Gene‐Related Peptide on Well‐Developed Canine Coronary Collateral Vasculature , 1993, Journal of cardiovascular pharmacology.

[34]  A. Timmis,et al.  Calcitonin gene-related peptide: a haemodynamic study of a novel vasodilator in patients with severe chronic heart failure. , 1992, International journal of cardiology.

[35]  M. Komajda,et al.  Plasma calcitonin gene-related peptide decreases in chronic congestive heart failure. , 1992, European heart journal.

[36]  F. Ledda,et al.  α.‐Adrenoceptor modulation of the efferent function of capsaicin‐sensitive sensory neurones in guinea‐pig isolated atria , 1992, British journal of pharmacology.

[37]  P. Danilo,et al.  Nonadrenergic noncholinergic innervation. Anatomic distribution of calcitonin gene-related peptide-immunoreactive tissue in the dog heart. , 1991, Circulation research.

[38]  C. Gennari,et al.  Improved cardiac performance with human calcitonin gene related peptide in patients with congestive heart failure. , 1990, Cardiovascular research.

[39]  M. Yacoub,et al.  Autoradiographic mapping of calcitonin gene-related peptide receptors in human and guinea pig hearts. , 1990, Circulation.

[40]  A. Saito,et al.  Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nerve-mediated vasodilation in the rat mesenteric resistance vessel , 1990, Brain Research.

[41]  R. Fiscus,et al.  Calcitonin gene-related peptide increases cAMP, tension, and rate in rat atria. , 1989, The American journal of physiology.

[42]  G. Tsujimoto,et al.  The first demonstration of CGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations. , 1989, Japanese journal of pharmacology.

[43]  T. Masaki,et al.  Positive Inotropic Effect of Calcitonin Gene‐Related Peptide Mediated by Cyclic AMP in Guinea Pig Heart , 1988, Circulation research.

[44]  N. Okamura,et al.  Effects of calcitonin gene-related peptide (CGRP) and isoproterenol on the contractility and adenylate cyclase activity in the rat heart. , 1987, Journal of molecular and cellular cardiology.

[45]  A. Franco‐Cereceda,et al.  Cardiovascular effects of calcitonin gene-related peptides I and II in man. , 1987, Circulation research.

[46]  H. Takagi,et al.  Possible mechanisms of positive inotropic action of synthetic human calcitonin gene-related peptide in isolated rat atrium , 1986, Peptides.

[47]  D. Kass,et al.  Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. , 1986, Circulation.

[48]  W. Little,et al.  The Left Ventricular dP/dtmax‐End‐Diastolic Volume Relation in Closed‐Chest Dogs , 1985, Circulation research.